The Department has been working continuously to ensure a stable long-term policy environment and reduce the compliance burden on the Industry.
With a mix of vaccines targeting different stages of COVID-19, the company is eyeing huge market potential
Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties
The company plans to use this funding to boost AI capabilities, expand vernacular content ecosystem, accelerate product development, and scale user acquisition across Tier 2 and Tier 3 markets
34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases
Intas Pharmaceuticals has appointed Girish Bhunje as Senior Vice President – API Operations
Rathi brings more than 15 years of experience in formulation research and development, with deep expertise across a wide range of dosage forms and drug delivery technologies.
As competition intensifies in the obesity treatment market, a next-generation therapy may be in development.
The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion
Clearing 19 biologics for Europe market
Subscribe To Our Newsletter & Stay Updated
